Stepan (SCL) Fundamental Analysis: Revenue, Earnings & Valuation

3.18 / 10

Netural

Fundamental analysis rates Stepan as neutral with a low 3.2/10 health score. Profit‑to‑market value and equity multiplier are modest positives, but cash‑flow growth, PB‑ROE and liquidity ratios are weak. Overall fundamental score is 3.18, indicating challenging investment case.

Analysis Checks(3/10)

Revenue-MV

Value1.30

Score0/3

Weight0.74%

1M Return0.22%

Net cash flow from operating activities per share (YoY growth rate %)

Value-9.24

Score0/3

Weight-1.20%

1M Return-0.35%

Profit-MV

Value0.58

Score3/3

Weight31.40%

1M Return6.99%

Net income-Revenue

Value-2.63

Score1/3

Weight7.84%

1M Return2.08%

PB-ROE

Value-0.61

Score1/3

Weight11.49%

1M Return3.13%

Cash-UP

Value-0.38

Score2/3

Weight11.12%

1M Return2.95%

Long-term debt to working capital ratio (%)

Value2.32

Score1/3

Weight8.40%

1M Return2.09%

Interest coverage ratio (EBIT / Interest expense) (%)

Value3.71

Score1/3

Weight6.76%

1M Return1.65%

Equity multiplier (DuPont analysis %)

Value1.93

Score2/3

Weight16.44%

1M Return3.76%

Current ratio

Value1.29

Score1/3

Weight7.01%

1M Return1.73%

Is SCL undervalued or overvalued?

SCL scores 3.18/10 on fundamentals and holds a Fair valuation at present. Backed by its 3.89% ROE, 2.01% net margin, 24.18 P/E ratio, 0.91 P/B ratio, and -7.24% earnings growth, these metrics solidify its Netural investment rating.